Thursday, March 07, 2024 10:18:25 AM
Knowledge is a wonderful thing, however, a tiny bit of knowledge is a dangerous thing.
If you go to a MM and tell them you have 200,000 shares to sell, they will often short on their desk to fulfill your order and then cover their short with your incoming securities. It's called MAKING A MARKET, and that is why they are called MARKET MAKERS!! Jeeeez. They are not outright shorts! They are tasked with executing orders in an orderly fashion, and that is what they are doing.
When more sale orders come in than buy orders, the stock goes LOWER, and vice versa... they do their best to match orders with the orders they have, be it buy or sell..
Just be quiet and let the adults do the work and the talking until you learn how things really work! The only thing wrong with this stock is the management and their decades of failures and deceit..
As usual, my posts are my opinions only.
If you go to a MM and tell them you have 200,000 shares to sell, they will often short on their desk to fulfill your order and then cover their short with your incoming securities. It's called MAKING A MARKET, and that is why they are called MARKET MAKERS!! Jeeeez. They are not outright shorts! They are tasked with executing orders in an orderly fashion, and that is what they are doing.
When more sale orders come in than buy orders, the stock goes LOWER, and vice versa... they do their best to match orders with the orders they have, be it buy or sell..
Just be quiet and let the adults do the work and the talking until you learn how things really work! The only thing wrong with this stock is the management and their decades of failures and deceit..
As usual, my posts are my opinions only.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
